Free Trial

AvePoint (AVPT) Financials

AvePoint logo
$10.28 -0.29 (-2.70%)
Closing price 05/6/2026 03:59 PM Eastern
Extended Trading
$10.30 +0.03 (+0.24%)
As of 04:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for AvePoint

Annual Income Statements for AvePoint

This table shows AvePoint's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-128 -51 -68 -42 -22 -29 35
Consolidated Net Income / (Loss)
-20 -17 -33 -39 -22 -29 35
Net Income / (Loss) Continuing Operations
-20 -17 -33 -39 -22 -29 35
Total Pre-Tax Income
-20 -16 -33 -34 -19 -24 41
Total Revenue
116 152 192 232 272 330 419
Net Interest Income / (Expense)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income
116 152 192 232 272 330 419
Other Non-Interest Income
116 152 192 232 272 330 419
Total Non-Interest Expense
135 167 245 273 290 355 379
Marketing Expense
73 89 133 142 148 172 197
Other Operating Expenses
61 77 112 131 139 152 190
Other Special Charges
-0.06 -0.04 - - 3.26 32 -7.47
Income Tax Expense
0.61 1.06 0.46 5.04 2.89 4.74 5.38
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 0.03 1.97 2.94 0.22 -0.05 0.32
Basic Earnings per Share
($1.72) ($0.57) ($0.48) ($0.23) ($0.12) ($0.16) $0.17
Weighted Average Basic Shares Outstanding
74.01M 89.64M 141.60M 181.96M 182.26M 183.72M 207.59M
Diluted Earnings per Share
($1.72) ($0.57) - - ($0.12) ($0.16) $0.15
Weighted Average Diluted Shares Outstanding
74.01M 89.64M 182.60M 191.40M 182.26M 183.72M 229.29M
Weighted Average Basic & Diluted Shares Outstanding
- 9.56M 182.60M 191.40M 184.01M 201.83M 215.47M

Quarterly Income Statements for AvePoint

This table shows AvePoint's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-13 -4.21 4.27 -1.72 -13 2.62 -17 3.44 2.70 13 16
Consolidated Net Income / (Loss)
-13 -4.23 4.44 -1.95 -13 2.93 -17 3.57 2.89 13 16
Net Income / (Loss) Continuing Operations
-13 -4.23 4.44 -1.95 -13 2.93 -17 3.57 2.89 13 16
Total Pre-Tax Income
-9.21 -1.39 -0.81 0.20 -9.11 3.11 -19 4.87 6.85 13 16
Total Revenue
65 73 75 75 78 89 89 93 102 110 115
Total Non-Interest Income
65 73 75 75 78 89 89 93 102 110 115
Other Non-Interest Income
65 73 75 75 78 89 89 93 102 110 115
Total Non-Interest Expense
74 73 73 74 80 86 83 90 95 97 97
Marketing Expense
37 37 39 40 43 43 45 47 49 50 51
Other Operating Expenses
35 36 35 37 37 38 39 43 46 52 49
Income Tax Expense
3.31 2.84 -5.25 2.16 3.83 0.18 -1.43 1.31 3.96 -0.21 0.32
Basic Earnings per Share
($0.07) ($0.02) $0.02 ($0.01) ($0.07) $0.01 ($0.09) $0.02 $0.01 $0.06 $0.08
Weighted Average Basic Shares Outstanding
183.32M 181.77M 182.26M 181.50M 182.80M 183.95M 183.72M 197.92M 205.07M 212.00M 207.59M
Diluted Earnings per Share
- ($0.02) - ($0.01) ($0.07) $0.01 - $0.02 $0.01 $0.06 $0.06
Weighted Average Diluted Shares Outstanding
185.40M 181.77M 184.01M 181.50M 182.80M 203.86M 201.83M 224.57M 229.18M 232.90M 229.29M
Weighted Average Basic & Diluted Shares Outstanding
185.40M 183.66M 184.01M 185.29M 186.72M 187.51M 201.83M 203.23M 211.93M 215.79M 215.47M

Annual Cash Flow Statements for AvePoint

This table details how cash moves in and out of AvePoint's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-4.22 57 199 -41 -4.03 68 190
Net Cash From Operating Activities
-2.05 19 5.03 -0.77 35 89 85
Net Cash From Continuing Operating Activities
-2.05 19 5.03 -0.77 35 89 85
Net Income / (Loss) Continuing Operations
-20 -17 -33 -39 -22 -29 35
Consolidated Net Income / (Loss)
-20 -17 -33 -39 -22 -29 35
Provision For Loan Losses
0.30 0.69 - - 0.00 0.00 4.04
Depreciation Expense
1.05 1.06 1.24 3.49 4.69 5.38 6.21
Non-Cash Adjustments to Reconcile Net Income
13 33 39 43 54 84 50
Changes in Operating Assets and Liabilities, net
4.13 1.30 -1.62 -8.27 -2.43 29 -10
Net Cash From Investing Activities
-1.48 1.37 -3.38 -21 -5.65 -2.60 -20
Net Cash From Continuing Investing Activities
-1.48 1.37 -3.38 -21 -5.65 -2.60 -20
Purchase of Property, Leasehold Improvements and Equipment
-1.08 -1.02 -2.46 -5.47 -3.52 -4.26 -5.31
Purchase of Investment Securities
- 2.39 -0.92 -200 -4.75 -3.57 -15
Sale and/or Maturity of Investments
-0.40 - 0.00 184 2.62 5.22 0.17
Net Cash From Financing Activities
-0.09 36 199 -17 -34 -16 124
Net Cash From Continuing Financing Activities
-0.09 36 199 -17 -34 -16 124
Issuance of Debt
150 0.28 - - 0.00 0.00 0.00
Repurchase of Common Equity
0.00 0.00 -108 -20 -39 -37 -50
Other Financing Activities, Net
-4.68 5.93 437 2.82 5.37 22 174
Effect of Exchange Rate Changes
-0.59 0.90 -1.17 -1.66 0.60 -3.18 1.28
Cash Interest Paid
0.00 0.00 4.04 3.32 6.11 6.88 6.83

Quarterly Cash Flow Statements for AvePoint

This table details how cash moves in and out of AvePoint's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Change in Cash & Equivalents
-9.11 -14 17 -7.67 12 23 41 61 78 42 9.42
Net Cash From Operating Activities
8.01 4.03 21 7.76 16 32 33 0.50 20 35 30
Net Cash From Continuing Operating Activities
8.01 4.03 21 7.76 16 32 33 0.50 20 35 30
Net Income / (Loss) Continuing Operations
-13 -4.23 4.44 -1.95 -13 2.93 -17 3.57 2.89 13 16
Consolidated Net Income / (Loss)
-13 -4.23 4.44 -1.95 -13 2.93 -17 3.57 2.89 13 16
Depreciation Expense
1.12 1.19 1.25 1.30 1.33 1.40 1.36 1.51 1.62 1.52 1.56
Non-Cash Adjustments to Reconcile Net Income
18 15 14 9.75 22 16 36 13 17 8.55 12
Changes in Operating Assets and Liabilities, net
1.84 -7.66 2.22 -1.34 6.25 12 12 -17 -1.38 7.71 0.40
Net Cash From Investing Activities
-3.28 -1.80 -1.42 -1.54 -1.05 1.22 -1.23 -17 -13 -0.86 11
Net Cash From Continuing Investing Activities
-3.28 -1.80 -1.42 -1.54 -1.05 1.22 -1.23 -17 -13 -0.86 11
Purchase of Property, Leasehold Improvements and Equipment
-0.95 -1.03 -1.06 -0.89 -0.73 -1.63 -1.01 -1.97 -1.33 -0.86 -1.16
Purchase of Investment Securities
-1.23 -1.50 -1.70 -0.89 -1.27 -1.20 -0.35 -15 -12 -0.14 12
Sale and/or Maturity of Investments
-1.10 0.73 1.33 0.24 0.95 4.04 0.12 0.00 - 0.14 0.03
Net Cash From Financing Activities
-13 -16 -3.86 -13 -2.86 -12 13 76 71 8.66 -31
Net Cash From Continuing Financing Activities
-13 -16 -3.86 -13 -2.86 -12 13 76 71 8.66 -31
Issuance of Debt
- - - - - - - - - - -6.06
Repurchase of Common Equity
-15 -17 -5.39 -14 -5.41 -6.54 -11 -12 -7.05 -8.36 -22
Other Financing Activities, Net
2.11 0.63 1.70 0.78 2.55 -5.85 24 88 78 11 -2.97
Effect of Exchange Rate Changes
-0.74 -0.13 1.25 -0.93 -0.75 1.77 -3.28 0.93 0.93 -0.81 0.24
Cash Interest Paid
2.61 2.86 0.32 0.98 2.29 2.28 1.33 0.90 1.51 2.29 2.13

Annual Balance Sheets for AvePoint

This table presents AvePoint's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
353 169 389 416 443 519 789
Cash and Due from Banks
0.99 69 268 227 223 291 481
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
- 2.66 3.92 5.54 5.12 5.29 6.02
Deferred Acquisition Cost
- 32 39 49 55 60 71
Goodwill
- - 0.00 19 19 18 38
Intangible Assets
- - 0.00 11 11 8.89 12
Other Assets
352 65 78 104 130 137 181
Total Liabilities & Shareholders' Equity
353 169 389 416 443 519 789
Total Liabilities
35 149 133 172 218 248 310
Short-Term Debt
0.61 0.77 1.82 1.52 1.38 2.35 3.81
Accrued Interest Payable
- 26 35 48 54 76 84
Other Short-Term Payables
0.01 65 74 93 122 144 186
Other Long-Term Liabilities
34 57 22 30 41 25 37
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
5.00 -193 250 229 219 271 479
Total Preferred & Common Equity
5.00 -193 250 229 211 269 479
Total Common Equity
5.00 -193 250 229 211 269 479
Common Stock
2.03 105 625 666 668 779 980
Retained Earnings
2.97 -300 -375 -417 -460 -510 -510
Accumulated Other Comprehensive Income / (Loss)
- 1.79 2.32 2.01 3.20 0.58 8.37
Noncontrolling Interest
- - - 0.00 8.21 1.79 0.00

Quarterly Balance Sheets for AvePoint

This table presents AvePoint's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets
395 402 399 398 414 427 463 599 700 744
Cash and Due from Banks
218 229 220 206 215 227 250 351 430 472
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
5.61 5.18 5.00 4.98 4.91 4.52 5.25 5.96 6.22 6.14
Deferred Acquisition Cost
42 48 49 50 53 52 55 60 63 65
Goodwill
18 19 19 19 19 18 19 37 39 38
Intangible Assets
11 11 11 10 10 9.81 9.71 12 12 12
Other Assets
100 90 95 108 112 116 124 133 150 150
Total Liabilities & Shareholders' Equity
395 402 399 398 414 427 463 599 700 744
Total Liabilities
149 160 173 184 201 220 247 237 257 277
Short-Term Debt
2.02 1.45 1.44 1.86 7.35 7.46 3.90 2.29 1.81 2.52
Accrued Interest Payable
- 35 42 45 41 47 57 56 68 83
Other Short-Term Payables
117 91 96 102 115 118 133 150 158 159
Other Long-Term Liabilities
30 32 34 35 38 47 53 29 29 32
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
233 227 211 200 213 207 216 361 443 467
Total Preferred & Common Equity
233 227 211 200 211 206 214 360 443 467
Total Common Equity
233 227 211 200 211 206 214 360 443 467
Common Stock
656 675 660 660 678 689 694 873 953 971
Retained Earnings
-404 -426 -451 -462 -470 -485 -484 -515 -518 -511
Accumulated Other Comprehensive Income / (Loss)
2.23 2.06 2.25 2.31 2.69 2.73 4.43 1.68 7.62 6.74
Noncontrolling Interest
- - - - 1.63 1.50 1.90 1.95 0.00 0.00

Annual Metrics And Ratios for AvePoint

This table displays calculated financial ratios and metrics derived from AvePoint's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - -
Profitability Metrics
- - - - - - -
Valuation Ratios
- - - - - - -
Leverage & Solvency
- - - - - - -
Liquidity Ratios
- - - - - - -
Cash Flow Metrics
- - - - - - -
Efficiency Ratios
- - - - - - -
Capital & Investment Metrics
- - - - - - -
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.48) ($0.23) ($0.12) ($0.16) $0.17
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 141.60M 181.96M 182.26M 183.72M 207.59M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.48) $0.00 $0.00 $0.00 $0.15
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 141.60M 191.40M 184.01M 201.83M 229.29M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 182.60M 191.40M 184.01M 201.83M 215.47M
Debt Service Ratios
- - - - - - -
Payout Ratios
- - - - - - -

Quarterly Metrics And Ratios for AvePoint

This table displays calculated financial ratios and metrics derived from AvePoint's official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.07) ($0.02) $0.02 ($0.01) ($0.07) $0.01 ($0.09) $0.02 $0.01 $0.06 $0.08
Adjusted Weighted Average Basic Shares Outstanding
183.32M 181.77M 182.26M 181.50M 182.80M 183.95M 183.72M 197.92M 205.07M 212.00M 207.59M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.01 $0.00 $0.02 $0.01 $0.06 $0.06
Adjusted Weighted Average Diluted Shares Outstanding
185.40M 183.66M 184.01M 185.29M 186.72M 203.86M 201.83M 224.57M 229.18M 232.90M 229.29M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
185.40M 183.66M 184.01M 185.29M 186.72M 187.51M 201.83M 203.23M 211.93M 215.79M 215.47M
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Financials Breakdown Chart

Key Financial Trends

AvePoint (AVPT) has shown a distinct improvement in profitability and liquidity through 2025, with a solid top-line growth trend and stronger quarterly cash flow. Below are the key trends based on the last four years of quarterly data across the income statement, balance sheet, and cash flow statements.

  • Revenue growth: Total Revenue rose through 2025, with Q4 2025 at 114,687,000 USD, up from 102,018,000 USD (Q2 2025) and 93,064,000 USD (Q4 2024), underscoring an improving top line.
  • Net income turns positive: Net income attributable to common shareholders reached 15,644,000 USD in Q4 2025, reversing the prior-year quarterly losses (Q4 2024 net income to common was negative), signaling a potential profitability inflection.
  • Healthy operating cash flow: Net cash from continuing operating activities was 29,659,000 USD in Q4 2025, contributing to a positive overall cash flow trend despite investing activity outlays.
  • Strong liquidity: Cash and cash equivalents were about 471,640,000 USD at Q3 2025, reflecting a robust liquidity position, with Total Assets around 743,515,000 USD and Total Common Equity of about 466,809,000 USD in the period.
  • Dilution and share-count dynamics: Weighted average shares outstanding (basic/diluted) and earnings per share have shown dilution pressures across the period (e.g., diluted shares around 232,897,000 in Q3 2025 and 229,293,000 in Q4 2025), which may impact per-share results going forward.
  • Investing activity remains a drag on cash: Net cash from continuing investing activities was negative in 2025 quarters (e.g., -13,473,000 USD in Q2 2025, -16,859,000 USD in Q1 2025, -10,989,000 USD in Q4 2025), reflecting ongoing capital expenditures and asset investments.
  • High non-interest expenses relative to revenue: In Q4 2025, Total Non-Interest Expense was 97,134,000 USD vs Total Revenue of 114,687,000 USD, implying an expense ratio around 85% and indicating ongoing margin pressure from operating costs.
  • Rising liabilities: Total Liabilities grew to about 276,706,000 USD by Q3 2025 (vs about 201,070,000 USD in Q2 2024 and 237,395,000 USD by Q2 2025), signaling increasing leverage that may warrant watching financing needs and debt management.
  • Profitability volatile across quarters: After early-year improvements in 2025, quarterly net income margins can still swing, and quarterly results have shown variability (e.g., Q1–Q4 2025 see a mix of positive and smaller-magnitude gains before the Q4 upturn).
  • Financing activity volatility: Net cash from financing activities fluctuates across quarters (e.g., +70.6M in Q2 2025, but large negative values in Q3 and Q4 2025), suggesting a reliance on market financing that could introduce liquidity risk if market conditions worsen.
05/07/26 05:27 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About AvePoint's Financials

When does AvePoint's fiscal year end?

According to the most recent income statement we have on file, AvePoint's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has AvePoint's net income changed over the last 6 years?

AvePoint's net income appears to be on a downward trend, with a most recent value of $35.12 million in 2025, falling from -$20.17 million in 2019. The previous period was -$29.14 million in 2024. View AvePoint's forecast to see where analysts expect AvePoint to go next.

How has AvePoint's revenue changed over the last 6 years?

Over the last 6 years, AvePoint's total revenue changed from $116.10 million in 2019 to $419.50 million in 2025, a change of 261.3%.

How much debt does AvePoint have?

AvePoint's total liabilities were at $310.48 million at the end of 2025, a 25.1% increase from 2024, and a 794.4% increase since 2019.

How much cash does AvePoint have?

In the past 6 years, AvePoint's cash and equivalents has ranged from $994.81 thousand in 2019 to $481.06 million in 2025, and is currently $481.06 million as of their latest financial filing in 2025.



Financial statements for NASDAQ:AVPT last updated on 2/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners